Skip to content

Serum Electrolyte Abnormalities as Prognostic Factor for Outcome in Critically Ill Children

Serum Electrolyte Abnormalities as Prognostic Factor for Outcome in Critically Ill Children

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07205562
Enrollment
200
Registered
2025-10-03
Start date
2025-10-01
Completion date
2026-12-01
Last updated
2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Children, Electrolytes Abnormalities, Prognostic Factors

Brief summary

The aim of this study is to evaluate the clinical profile and outcome of children with serum electrolyte abnormalities admitted at Pediatric Intensive Care Unit in Assuit University Children Hospital.

Detailed description

Electrolyte imbalances are frequent and potentially life-threatening disturbances encountered in pediatric intensive care units (PICUs). These imbalances can reflect underlying pathological processes, treatment interventions, or both, and may influence the clinical course and outcomes of critically ill children. The homeostasis of electrolytes such as sodium, potassium, calcium, and magnesium plays a central role in cellular function, nerve conduction, and cardiovascular stability, making their monitoring and correction crucial during pediatric critical illness . Studies have highlighted that disturbances like hyponatremia, hyperkalemia, or hypocalcemia often serve as early indicators of disease severity or progression. Kiran and Chaudhary\[2021\]observed that children admitted with electrolyte abnormalities frequently experienced higher morbidity and mortality compared to those without such disturbances, suggesting a direct correlation with outcomes in the PICU setting . These abnormalities may arise from diverse etiologies, including dehydration, renal dysfunction, endocrinal disorder and hypothalamic disorder, sepsis, gastrointestinal losses, or medication effects Electrolyte derangements are particularly prevalent among pediatric patients presenting to emergency departments, with age-related differences in presentation and underlying causes. Yen et al. demonstrated that younger children were more prone to sodium and potassium imbalances due to immature renal handling and higher fluid turnover, while older children exhibited abnormalities associated with chronic illnesses or pharmacological agents .Recognizing these patterns can aid in risk stratification and individualized management strategies The spectrum of electrolyte emergencies in children is broad and necessitates rapid identification and intervention. Zieg et al. underscored that life-threatening complications such as arrhythmias, seizures, and cerebral edema often arise from untreated or mismanaged electrolyte disorders, especially in the PICU environment . Hence, early diagnosis and understanding of etiological factors are pivotal in improving clinical outcomes and preventing complications. Local demographic and regional healthcare factors may also influence the incidence and types of electrolyte abnormalities. In a study from a tertiary care center, Routray et al. found significant variation in electrolyte imbalance profiles across different age groups and disease categories, emphasizing the importance of context-specific evaluation in pediatric populations . Such data are essential for tailoring protocols in resource-limited settings Recent studies such as the one by Rewers et al. on diabetic ketoacidosis have demonstrated that fluid rehydration strategies can impact the rate of correction of acidosis and electrolyte derangements. Their findings highlighted the importance of fluid composition and timing in achieving rapid stabilization without causing further complications . Such protocols are particularly relevant in pediatric patients with metabolic derangements Finally, the overall impact of electrolyte disorders on mortality in the PICU has been underscored in several investigations. Haider et al. found a statistically significant association between electrolyte imbalance and increased risk of death among critically ill children, stressing the need for early intervention and continuous monitoring as part of comprehensive PICU care .

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
1 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children aged 1 month to 18 years. * Admission to the PICU for any acute medical or surgical reason. * Availability of serum electrolyte data within the first 24 hours of admission

Exclusion criteria

* Children with known chronic kidney disease and chronic liver disease * Patients with incomplete medical records or missing electrolyte data. * Children discharged or deceased within 6 hours of admission. * Patients with chronic liver diseases, or previously diagnosed with adrenal gland disorders

Design outcomes

Primary

MeasureTime frameDescription
Incidence and Correlation of Electrolyte Abnormalities With PICU Mortalityaverage of hospital stay: up to 28 daysTo determine the frequency and distribution of electrolyte abnormalities (sodium, potassium, calcium, magnesium, phosphate, and chloride) in critically ill children admitted to the PICU, and to evaluate their correlation with PICU mortality.

Secondary

MeasureTime frameDescription
Risk Factors and Clinical Outcomes Correlated With Electrolyte Abnormalities in PICU Patientsaverage hospital stay: up to 28 daysTo identify potentially modifiable risk factors for developing electrolyte abnormalities in critically ill children admitted to the PICU, and to evaluate their correlation with adverse clinical outcomes, including prolonged PICU stay, need for mechanical ventilation, and morbidity indicators (seizures, arrhythmias, altered mental status).

Contacts

Primary ContactMenna Allah Ahmed Hussein, Principal Investigator
Menna.17289766@med.aun.edu.eg+201092583368

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026